0.6500
0.0000
(0.00%)
At close: January 17 at 3:42:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.51M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| TARRIFF SCOTT L Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| CAHILL BRIAN JOSEPH Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| TARRIFF SCOTT L Chief Executive Officer | Sale at price 13.82 - 13.87 per share. | Direct | 299,309 | Nov 2, 2023 |
| GRAVES MICHAEL JOSEPH Director | Conversion of Exercise of derivative security at price 4.94 per share. | Direct | 46,238 | Oct 27, 2023 |
| TARRIFF SCOTT L Chief Executive Officer | Sale at price 14.41 - 15.23 per share. | Direct | 300,026 | Oct 3, 2023 |
| TARRIFF SCOTT L Chief Executive Officer | Sale at price 19.98 per share. | Direct | 299,700 | May 16, 2023 |
| TARRIFF SCOTT L Chief Executive Officer | Sale at price 19.69 - 21.52 per share. | Direct | 930,656 | May 15, 2023 |
| TARRIFF SCOTT L Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| CAHILL BRIAN JOSEPH Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
Related Tickers
006280.KS GC Biopharma Corp.
145,100.00
-1.76%
74D.F HLS Therapeutics Inc.
2.6000
0.00%
H5P.F Hikma Pharmaceuticals PLC
24.60
-0.81%
ANIK Anika Therapeutics, Inc.
16.07
-0.74%
23I.F Intra-Cellular Therapies, Inc.
121.00
-0.82%
ANIP ANI Pharmaceuticals, Inc.
58.46
+1.67%
CEL.L Celadon Pharmaceuticals Plc
22.50
+2.27%
BGXX Bright Green Corporation
0.0845
+11.18%
LFCR Lifecore Biomedical, Inc.
6.48
+0.62%
COLL Collegium Pharmaceutical, Inc.
33.35
-0.33%